Advanced BioScience Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Advanced BioScience Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3395
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract manufacturing company that provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. The company develops therapeutics, vaccines, and other biologic products. It provides proof-of-concept in vivo studies with potency testing, preclinical immunomonitoring, and efficacy. ABL’s services include upstream cell culture, technology transfer, contract research services and contract manufacturing services. The company’s contract research and contract manufacturing services include cGMP virus banking, virus seed stock development, plaque purification, viral lysate production, downstream purification development, production of toxicology supply, upstream process development, and production of clinical supply. ABL is headquartered in Rockville, Maryland, the US.

Advanced BioScience Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Advanced BioScience Labs Acquires Production Asset of Transgene 11
Partnerships 12
ABL Enters into Development Agreement with Najit Technologies 12
ABL Enters into Contract Manufacturing Agreement with RegenxBio 13
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 14
Asset Transactions 15
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 15
Advanced BioScience Laboratories Inc – Key Competitors 17
Advanced BioScience Laboratories Inc – Key Employees 18
Advanced BioScience Laboratories Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
May 11, 2017: ABL Increases Aseptic Fill/Finish Capacity with State-of-the-Art, Fully Automated Vial Filling Line 20
Corporate Communications 21
Jun 04, 2018: ABL Announces Hiring of Marykay Marchigiani as Chief Financial Officer 21
Other Significant Developments 22
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Advanced BioScience Labs Acquires Production Asset of Transgene 11
ABL Enters into Development Agreement with Najit Technologies 12
ABL Enters into Contract Manufacturing Agreement with RegenxBio 13
Advanced BioScience Enters Into Co-Marketing Agreement With Calixar 14
Bioqual Completes Acquisition Of In-Vivo Animal Model Services Related Assets From ABL 15
Advanced BioScience Laboratories Inc, Key Competitors 17
Advanced BioScience Laboratories Inc, Key Employees 18
Advanced BioScience Laboratories Inc, Subsidiaries 19

List of Figures
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Advanced BioScience Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Advanced BioScience Laboratories Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Advanced BioScience Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allianz Group:企業の戦略・SWOT・財務情報
    Allianz Group - Strategy, SWOT and Corporate Finance Report Summary Allianz Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sanmina Corp (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corp (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Knight-Swift Transportation Holdings Inc. (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc. (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Tethys Oil AB (TETY):石油・ガス:M&Aディール及び事業提携情報
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • Goldcorp Inc:企業のM&A・事業提携・投資動向
    Goldcorp Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goldcorp Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Xylem Inc (XYL)-エネルギー分野:企業M&A・提携分析
    Summary Xylem Inc. (Xylem) is a water technology company that designs, manufactures, and service engineered technologies for water industry. The company’s products portfolio includes testing equipment; filtration, disinfection and biological treatment equipment; controls and systems; and water and w …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Chemed Corp (CHE):企業の財務・戦略的SWOT分析
    Summary Chemed Corp (Chemed) is a diversified company. The company operates through its segments including Vitas and Roto-Rooter. Its Vitas segment provides end-of-life hospice care for heart disease, stroke, multiple sclerosis, lung disease, liver disease, and kidney diseases, among others. Chemed …
  • Mead Johnson Nutrition Company:企業の戦略・SWOT・財務情報
    Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report Summary Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tiger Brands Ltd (TBS):企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Nestle (Malaysia) Bhd:戦略・SWOT・企業財務分析
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Whatabrands LLC:企業の戦略・SWOT・財務情報
    Whatabrands LLC - Strategy, SWOT and Corporate Finance Report Summary Whatabrands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oman Oil Marketing Co (OOMS):企業の財務・戦略的SWOT分析
    Summary Oman Oil Marketing Co (Oman Oil), a subsidiary of Oman Oil Company SAOC, is an oil and gas company that distributes and markets petroleum products. The company provides products such as lubricants, fuel cards, aviation fuels, commercial fuels and bunkering marine fuels, among others. It offe …
  • Jyoti Structures Ltd (JYOTISTRUC):企業の財務・戦略的SWOT分析
    Jyoti Structures Ltd (JYOTISTRUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Luxair S.A.:企業の戦略・SWOT・財務情報
    Luxair S.A. - Strategy, SWOT and Corporate Finance Report Summary Luxair S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Continental Resources, Inc.:企業の戦略・SWOT・財務分析
    Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Continental Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Aerosup Inc.:企業の戦略・SWOT・財務分析
    Aerosup Inc. - Strategy, SWOT and Corporate Finance Report Summary Aerosup Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Metabolomic Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Technologies Inc (MTI) is a diagnostic company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastroint …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆